Business Context and Reporting Period
This Form 6-K filing by GSK plc, dated November 11, 2024, serves as a report of a foreign private issuer. The document announces provisional dividend dates for the fiscal year 2025. It does not contain financial results for a specific reporting period but rather outlines the schedule for future dividend distributions.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is exclusively focused on the administrative schedule for dividend payments.
Material Changes
No material changes to financial performance or operations are reported in this filing. The content is limited to the announcement of indicative dates for the 2025 dividend cycle.
Guidance, Outlook, and Unusual Items
Management commentary is restricted to the announcement of dividend dates. The filing explicitly states that the provided dates are indicative and may be subject to change. No specific guidance on future earnings or risks is included in this text.
| Quarter | Results Announcement | Ordinary Shares Ex-Dividend | ADS Ex-Dividend | Payable Date |
|---|---|---|---|---|
| Q1 2025 | April 30, 2025 | May 15, 2025 | May 16, 2025 | June 19, 2025 |
| Q2 2025 | July 30, 2025 | August 14, 2025 | August 15, 2025 | September 18, 2025 |
| Q3 2025 | October 29, 2025 | November 13, 2025 | November 14, 2025 | December 15, 2025 |
| Q4 2025 | February 4, 2026 | February 19, 2026 | February 20, 2026 | March 17, 2026 |
Investor Verification Checklist
- Verify that the dividend dates listed are indicative and subject to change prior to the ex-dividend dates.
- Confirm the final dividend amounts and payment details in the official results announcements scheduled for April, July, October 2025, and February 2026.
- Check for any subsequent filings that may update the ex-dividend or record dates for Ordinary Shares and American Depositary Shares (ADS).